Combination therapy for treatment of female breast cancer
US4666885A · kind A · utility
27Cited by
11References
34Claims
0Family size
Inventor
Key dates
| Filing date | Feb 8, 1985 |
| Grant date | May 19, 1987 |
| Priority date | — |
| Expiry date | Feb 8, 2005 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S930/13
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of treatment of breast cancer in susceptible animals whose ovarian hormonal secretions are blocked by surgical or chemical means, e.g., by use of an LH-RH agonist, e.g., [D-Trp.sup.6, des-Gly-NH.sub.2.sup.10 ]LH-RH ethylamide with a therapy comprising administering an antiandrogen, e.g., flutamide and an optionally, an inhibitor of adrenal sex steroid biosynthesis e.g., aminoglutethimide, pharmaceutical compositions useful for such treatment and two, four and five component pharmaceutical kits containing such compositions are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.